Free Trial

Glanbia (LON:GLB) Sets New 1-Year Low - Here's Why

Glanbia logo with Consumer Defensive background
Remove Ads

Glanbia plc (LON:GLB - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as GBX 9.65 ($0.12) and last traded at GBX 9.65 ($0.12), with a volume of 110509 shares changing hands. The stock had previously closed at GBX 10.10 ($0.13).

Glanbia Price Performance

The company has a market capitalization of £2.37 billion, a PE ratio of 18.48, a PEG ratio of 8.32 and a beta of 0.47. The company has a current ratio of 1.63, a quick ratio of 0.86 and a debt-to-equity ratio of 48.90. The company's 50 day moving average price is GBX 11.99 and its 200-day moving average price is GBX 13.67.

Glanbia Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, May 2nd. Investors of record on Thursday, March 20th will be issued a dividend of €0.23 ($0.26) per share. This is an increase from Glanbia's previous dividend of $0.16. This represents a dividend yield of 2.18%. The ex-dividend date is Thursday, March 20th. Glanbia's dividend payout ratio (DPR) is presently 7,340.94%.

Insider Activity at Glanbia

In related news, insider Hugh McGuire sold 42,719 shares of the firm's stock in a transaction dated Friday, March 28th. The stock was sold at an average price of GBX 1,055 ($13.48), for a total transaction of £450,685.45 ($575,882.25). 30.55% of the stock is currently owned by corporate insiders.

About Glanbia

(Get Free Report)

We are a better nutrition company, home to consumer brands and ingredients that help people around the world feel strong, nourished, and to perform well at any age. Everything we do has real nutritional benefit. Everything we do is in pursuit of better, for each other and the planet.

Read More

Should You Invest $1,000 in Glanbia Right Now?

Before you consider Glanbia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.

While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn how options trading can help you navigate market volatility, manage risk, and maximize returns with MarketBeat's "Unlock the Potential in Options Trading." Click the link below to have this special report delivered to your inbox.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads